# Study of the Effects of Intravenous Exenatide on Cardiac Repolarization

> **NCT02650479** · PHASE1 · COMPLETED · sponsor: **Intarcia Therapeutics** · enrollment: 82 (actual)

## Conditions studied

- Healthy Adult Male and Female Volunteers

## Interventions

- **DRUG:** Exenatide
- **DRUG:** Placebo
- **DRUG:** Moxifloxacin
- **DRUG:** Palonosetron

## Key facts

- **NCT ID:** NCT02650479
- **Lead sponsor:** Intarcia Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2017-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02650479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02650479, "Study of the Effects of Intravenous Exenatide on Cardiac Repolarization". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02650479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*